Drugs in R & D

, Volume 1, Issue 1, pp 92–94 | Cite as

MEDI 500

Anti-TCR-αβ Monoclonal Antibody T10B9, G 022, T-10B9, T10B9, T10B9 Monoclonal Antibody, T10B9.1A31, T12A10
Adis R&D Profile


Acute GVHD Transplant Rejection Heart Lung Transplant Renal Allograft Rejection Heart Transplant Rejection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lucas BA, Waid TH, Thompson JS, et al. Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection. Trans Proc 1993 Feb; 25 Pt 1: 54–5Google Scholar
  2. 2.
    Waid TH, Lucas BA, Thompson JS, et al. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial. Transplantation 1997 Jul 27; 64: 274–81PubMedCrossRefGoogle Scholar
  3. 3.
    Thompson JS, Brown SA, Barve S. Mechanism of immunosuppression by the murine IgM anti-T cell monoclonal antibody (mAb) T10B9.1A-31 (T10B9). J Cell Biochem 1995; Suppl. 21A: 179Google Scholar
  4. 4.
    Thompson JS, Brown SA, Barve S. T10B9.1A-31: a study of biofunctions important in the induction of tolerance. International Congress on New Immunosuppressive Drugs; 1995 Aug 27: 40Google Scholar
  5. 5.
    Brown SA, Lucas BA, Waid TH, et al. T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action. Clin Transplant 1996 Dec; 10 Pt 2: 607–13PubMedGoogle Scholar
  6. 6.
    Henslee-Downey PJ, Parrish RS, Macdonald JS, et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. Transplantation 1996 Mar 15; 61: 738–45PubMedCrossRefGoogle Scholar
  7. 7.
    Waid TH, Thompson JS, McKeown JW, et al. Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study. J Heart Lung Transplant 1997 Sep; 16: 913–16PubMedGoogle Scholar
  8. 8.
    Waid TH, Sekela ME, Thompson JS, et al. Induction therapy with T10B9.1A31 is equivalent to OKT3 in cardiac allograft recipients. J Heart Lung Transplant 1995 Jan–Feb; 14 Pt 2: 50Google Scholar

Copyright information

© Adis International Limited 1999

Personalised recommendations